Recursion Pharmaceuticals Inc's (NYSE: RXRX) short interest as a percent of float has fallen 15.85% since its last report.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

In 2017, fresh off a PhD on theoretical chemistry, John Jumper heard rumors that Google DeepMind had moved on from building ...

The HackerEarth platform itself is pretty standard for online coding tests. You’ll have a code editor where you write your ...

If the company is forced to offload even 100,000 of its 649,870 coins to meet obligations, it could trigger a systemic ...

The exponential increase in medical imaging data has intensified the need for accurate and efficient diagnostic analysis. Conventional methods often fail to ...

Many users feel they’re talking to a real person. Scientists say it’s time to consider whether they’re onto something.

Power first, models second AI is no longer constrained primarily by algorithms or capital; it is constrained by electrons.

At Industrial Wireless Forum, industry leaders explored how agentic AI running on private 5G is transforming factories and plants.

The newly described microbe represents a world of parasitic, intercellular biodiversity only beginning to be revealed by ...

Your LeetCode profile is more than just a list of solved problems. It’s a story about your coding journey, your ...

Understand flash loan security risks and exploits. Learn how attackers manipulate oracles and governance, and discover best ...